產品分類

    Products

    產品中心/ PRODUCTS

    我的位置:首頁  >  產品中心  >    >  動物活體成像設備  >  腫瘤測量儀

    腫瘤測量儀

    • 更新時間:2024-10-11
    • 訪  問  量:891

    簡要描述:動物腫瘤測量儀,非常適合對大鼠小鼠等動物的皮下腫瘤進行快速測量、分析,精確測量動物腫瘤并對腫瘤信息存檔與跟蹤

    在線咨詢

    聯系電話:021-54377179

    產品詳情

    動物腫瘤測量儀,非常適合對大鼠小鼠等動物的皮下腫瘤進行快速測量、分析,精確測量動物腫瘤并對腫瘤信息存檔與跟蹤。


    主要技術參數: 

    · 測量范圍:0-25mm腫瘤尺寸:20*20*20mm
    · 3D測量精確度:<0.3mm
    · 圖像捕捉時間:0.1s
    · 接口:USB 2.0
    · 相機:1600*1200 像素(2MP)
    · 工作距離:50mm


    動物腫瘤測量分析儀的主要特點: 
    · 手持式成像裝置,實現立體成像;
    · 適合測量不同尺寸的腫瘤;
    · 方便使用:觸屏式電腦,操作方便;
    · 內置軟件,自動計算腫瘤尺寸,跟蹤整個實驗進展。 
      

    · 快速,高效,保證了高通量和可靠測量;
    · 全自動測量跟蹤系統;
    · 實時數據分析與處理。 


         
      
     


    部分用戶: 

    Hunter College, CUNY

    Vanderbilt University Medical Center

    Hainan Medical University

    Howard Hughes Medical Institute

    Memorial Sloan Kettering Cancer Center

    Cancer Center Amsterdam

    GlaxoSmithKline

    Imec

    K.U.Leuven

    Neuro-Electronics Research Flanders

    Pepric

    PharmaVize

    reMYND

    University Ghent

    SEPS Pharma

    Vlaams Instituut voor Biotechnologie

    University Antwerp

    ThromboGenics

    Janssen Pharmaceutica

    City University of Hong Kong


    參考文獻:

    1.Adams EJ, Karthaus WR, Hoover E, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571(7765):408-412. doi:10.1038/s41586-019-1318-9.
    2.Zhang Z, Zhou C, Li X, et al. Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation. Cancer Cell. 2020;37(4):584-598.e11. doi:10.1016/j.ccell.2020.03.001.
    3.Santich BH, Park JA, Tran H, et al. Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies. Sci Transl Med. 2020;12(534):eaax1315. doi:10.1126/scitranslmed.aax1315.
    4.Park JA, Xu H, Cheung, I, et al. Abstract B38: Tetravalent bispecific antibodies specific for HER2 and disialoganglioside GD2 to engage polyclonal T cells for osteosarcoma therapy. Cancer Res. 2018;78(19),B38.doi:10.1158/1538-7445.PEDCA17-B38.
    5.Wu CF, Wu CY, Lin CF, et al. The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice. Biomed Pharmacother. 2022;151:113128. doi:10.1016/j.biopha.2022.113128.
    6.Wang L, Hoseini SS, Xu H, et al. Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency. Cancer Immunol Res. 2019;7(12):2013-2024. doi:10.1158/2326-6066.CIR-19-0121.
    7.Grochowska A, Statkiewicz M, Kulecka M, et al. Evidence supporting the oncogenic role of BAZ1B in colorectal cancer. Am J Cancer Res. 2022;12(10):4751-4763. 
    8.Hoseini SS, Vadlamudi M, Espinosa-Cotton M, et al. T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. J Immunother Cancer. 2021;9(5):e002509. doi:10.1136/jitc-2021-002509.
    9.Beguin E, Gray MD, Logan KA, et al. Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device. J Control Release. 2020;317:23-33. doi:10.1016/j.jconrel.2019.11.013.
    10.Mao N, Gao D, Hu W, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18(9):1577-1586. doi:10.1158/1535-7163.MCT-18-1386.
    11.Wu Z, Guo HF, Xu H, et al. Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers. Mol Cancer Ther. 2018;17(10):2164-2175. doi:10.1158/1535-7163.MCT-18-0026.
    12.Poty S, Mandleywala K, O'Neill E, et al. 89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma. Theranostics. 2020;10(13):5802-5814. doi:10.7150/thno.44772.
    13.Hoseini SS, Guo H, Wu Z, et al. A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia. Blood Adv. 2018;2(11):1250-1258. doi:10.1182/bloodadvances.2017014373.
    14.Zhang Z, Karthaus WR, Lee YS, et al. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer. Cancer Cell. 2020;38(2):279-296.e9. doi:10.1016/j.ccell.2020.06.005.
    15.Poty S, Carter LM, Mandleywala K, et al. Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2019;25(2):868-880. doi:10.1158/1078-0432.CCR-18-1650.




        

        

        :,

             

        :

        yuyanbio

        :yuyanbio

        

    在線咨詢

    留言框

    • 產品:

    • 您的單位:

    • 您的姓名:

    • 聯系電話:

    • 常用郵箱:

    • 省份:

    • 詳細地址:

    • 補充說明:

    • 驗證碼:

      請輸入計算結果(填寫阿拉伯數字),如:三加四=7
    上海玉研科學儀器有限公司
    地址:上海市閔行區興梅路485號眾欣大廈506室
    郵箱:sales@yuyanbio.com
    傳真:021-35183767
    掃一掃關注我們
    SCAN
    精品久久久久中文字幕一区| 人妻少妇精品久久| 日韩毛片免费观看一区| 国产精品视频九九九| 国产精品免费观看调教网| 日韩美女免费福利视频| 久久永久免费人妻精品下载| 91久久精品国产一区二区| 免费精品国自产拍在线播放| 黄页网站三级视频在线播放| 亚洲综合国产精品第一页| 青青热久久国产久精品| 欧美日韩一区二区在线观看视频 | 亚欧洲精品在线视频免费观看 | 久久久久无码精品国产app| 国产精品无码无卡无需播放器| 婷婷成人国产精品| 精品无码一区二区三区爱欲九九| 亚洲AV无码精品色午夜在线观看| 青草青草久热精品视频99| 99精品无人区乱码在线观看| 国产精品揄拍100视频| 国产精品乱视频| 成人国产精品动漫欧美一区| 四虎影永久在线观看精品| 欧美亚洲国产成人精品| 秋霞午夜鲁丝片午夜精品久| 欧美日韩精品| 潮喷大喷水系列无码久久精品| 国产一区二区三区欧美精品| 精品国产午夜福利在线观看| 真实国产乱子伦精品视频| 欧美日激情日韩精品| 国产精品爱搞视频网站 | HEYZO无码综合国产精品227| 久久精品人妻一区二区三区| 99精品国产一区二区三区2021| 亚洲国产精品一区二区三区久久 | 精品一区二区三区在线观看视频| 国产欧美日本亚洲精品一5| 色婷婷在线精品国自产拍|